↓ Skip to main content

Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial

Overview of attention for article published in Trials, October 2019
Altmetric Badge

Mentioned by

twitter
4 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
71 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial
Published in
Trials, October 2019
DOI 10.1186/s13063-019-3676-x
Pubmed ID
Authors

Francesco Cellini, Stefania Manfrida, Francesco Deodato, Savino Cilla, Ernesto Maranzano, Stefano Pergolizzi, Fabio Arcidiacono, Rossella Di Franco, Francesco Pastore, Matteo Muto, Valentina Borzillo, Costanza Maria Donati, Giambattista Siepe, Salvatore Parisi, Antonia Salatino, Antonino D’Agostino, Giampaolo Montesi, Anna Santacaterina, Vincenzo Fusco, Mario Santarelli, Maria Antonietta Gambacorta, Renzo Corvò, Alessio Giuseppe Morganti, Valeria Masiello, Paolo Muto, Vincenzo Valentini

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 71 100%

Demographic breakdown

Readers by professional status Count As %
Other 9 13%
Researcher 9 13%
Student > Master 7 10%
Student > Doctoral Student 4 6%
Unspecified 4 6%
Other 9 13%
Unknown 29 41%
Readers by discipline Count As %
Medicine and Dentistry 23 32%
Nursing and Health Professions 5 7%
Unspecified 4 6%
Physics and Astronomy 2 3%
Biochemistry, Genetics and Molecular Biology 1 1%
Other 3 4%
Unknown 33 46%